Blog

That the biggest pharmaceutical innovations have often been accidental isn’t a secret. Research has even shown that happy accidents or serendipity may be statistically significant. Generally, that’s good news for an R&D-driven sector like pharma. Still, it’s worth asking how to create the conditions for or increase the chances of getting lucky. A recent NY… Read More

The scientific challenges in identifying promising new compounds and bringing them to market may be the most difficult part of new drug development. But the costs and challenges associated with clinical trials is increasingly viewed as another significant barrier, according to a new study from the U.S. Department of Health and Human Services. The major… Read More

Accutane AEs Highlight the Need for Better and Faster Insights Over time, the pharmaceutical and life sciences sector has come to recognize that drug safety is not strictly a concern during research or clinical trials, but rather an ongoing objective. Further, there is an increasing sense that pharmaceuticals can do more to ensure their drugs… Read More

When it comes to seeing how real people actually respond to drugs and medications in the real world, most pharmaceuticals have more than enough data, but too little perspective. What’s missing is a clear, complete and holistic picture of drug effects on real people in the real world. Here’s where the multi-source advantage comes into… Read More

DIA’s 2015 conference highlighted the increasing urgency and rapid evolution within the pharmacovigilance (PV) space. There was a great deal of discussion around the use of social media for PV purposes. Certainly, the audience’s reaction to the presentation given by Ran Balicer, MD, PhD, MPH, demonstrated the urgency around social media. Dr. Balicer’s talk, Real-World,… Read More

Enhanced PV: Pharmacovigilance teams are under pressure to increase both efficiency and effective – that is, they must review more data sooner, monitor more broadly and diligently across the drug lifecycle, and report more accurately. Real-world intelligence and signals can lead to improved insights as well as increased efficiency. It enables PV specialists to spend… Read More

In the past, it was difficult to know for sure. But today, real-world intelligence makes it easier to track the reactions and experiences of actual patients. In fact, pharmaceuticals can use signals from social media, clinical electronic health records and other sources to ensure their drugs are performing as expected. They can even gain insight… Read More